CN100443499C - 高纯度白蛋白生产方法 - Google Patents
高纯度白蛋白生产方法 Download PDFInfo
- Publication number
- CN100443499C CN100443499C CNB2006101006176A CN200610100617A CN100443499C CN 100443499 C CN100443499 C CN 100443499C CN B2006101006176 A CNB2006101006176 A CN B2006101006176A CN 200610100617 A CN200610100617 A CN 200610100617A CN 100443499 C CN100443499 C CN 100443499C
- Authority
- CN
- China
- Prior art keywords
- albumin
- solution
- matrix
- chromatography
- ion
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70571—Receptors; Cell surface antigens; Cell surface determinants for neuromediators, e.g. serotonin receptor, dopamine receptor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/76—Albumins
- C07K14/765—Serum albumin, e.g. HSA
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/10—Fusion polypeptide containing a localisation/targetting motif containing a tag for extracellular membrane crossing, e.g. TAT or VP22
Abstract
Description
# | 保留时间(min) | 面积(uV.sec) | 高(uV) |
1 | 0.800 | 3459686 | 219122 |
2 | 1.667 | 418606 | 33569 |
3 | 2.150 | 77883335 | 1963630 |
4 | 3.000 | 6293258 | 122295 |
5 | 20.433 | 297608 | 14424 |
6 | 22.900 | 205822 | 14601 |
7 | 27.567 | 150851 | 10835 |
8 | 31.117 | 2213883 | 170938 |
9 | 37.983 | 164710 | 15088 |
10 | 39.267 | 347946 | 29879 |
11 | 41.750 | 107515 | 8402 |
12 | 42.783 | 2303024 | 192911 |
13 | 43.217 | 139744 | 14141 |
14 | 43.457 | 254521 | 23979 |
15 | 50.467 | 152805 | 13226 |
16 | 50.950 | 162364 | 12577 |
17 | 56.533 | 5753796 | 83674 |
# | 保留时间(min) | 面积(uV.sec) | 高(uV) |
1 | 0.350 | 244385 | 23957 |
2 | 0.633 | 607880 | 45310 |
3 | 0.783 | 3239730 | 243477 |
4 | 0.983 | 1072033 | 158146 |
5 | 2.233 | 76773569 | 2038028 |
6 | 2.933 | 6634089 | 182363 |
7 | 3.733 | 2812688 | 95459 |
8 | 12.483 | 818540 | 20185 |
9 | 12.650 | 218748 | 22750 |
10 | 14.150 | 5423715 | 98336 |
11 | 16.333 | 423403 | 17460 |
12 | 16.633 | 688525 | 24538 |
13 | 17.550 | 2301309 | 84781 |
14 | 18.033 | 1145045 | 47806 |
15 | 19.750 | 672721 | 21562 |
16 | 20.233 | 87799 | 9760 |
17 | 20.700 | 272171 | 13003 |
18 | 21.100 | 862146 | 55792 |
19 | 21.967 | 166471 | 8928 |
20 | 22.883 | 1381445 | 97660 |
21 | 23.583 | 1112632 | 89851 |
22 | 24.000 | 4740347 | 419780 |
23 | 24.417 | 352486 | 26374 |
24 | 24.917 | 171279 | 14625 |
25 | 25.133 | 99734 | 11473 |
26 | 25.267 | 133911 | 10515 |
27 | 25.667 | 223556 | 11854 |
# | 保留时间(min) | 面积(uV.sec) | 高(uV) |
29 | 26.600 | 93906 | 7957 |
30 | 26.817 | 223113 | 18326 |
31 | 27.250 | 303831 | 29461 |
32 | 27.533 | 124218 | 12710 |
33 | 27.783 | 5747091 | 561629 |
34 | 28.550 | 1383761 | 119772 |
35 | 29.033 | 390986 | 33455 |
36 | 29.417 | 182131 | 12713 |
37 | 29.833 | 181333 | 12584 |
38 | 30.183 | 478320 | 30155 |
39 | 30.583 | 1048945 | 58465 |
40 | 31.067 | 3454425 | 214489 |
41 | 31.983 | 168275 | 8663 |
42 | 32.717 | 651406 | 43161 |
43 | 33.150 | 1142221 | 102588 |
44 | 34.017 | 420756 | 23883 |
45 | 35.100 | 115704 | 10008 |
46 | 37.033 | 166588 | 9468 |
47 | 38.267 | 145731 | 8078 |
48 | 38.983 | 781209 | 54029 |
49 | 41.800 | 86967 | 8868 |
50 | 48.883 | 95416 | 8522 |
51 | 50.267 | 174159 | 16737 |
52 | 50.483 | 176115 | 15573 |
53 | 51.267 | 158727 | 13701 |
54 | 52.183 | 297278 | 25795 |
55 | 56.533 | 5846645 | 85710 |
样品 | 序列 |
脱-Leu rHA | LVAASQAALGAWAVARDLGEENFK |
HSA标准品 | AWAVARDLGEENFK+about5%LVAASQAALG |
HSA30℃下12周 | AWAVARDLGEENFK |
rHA4℃下6个月 | AWAVARDLGEENFK |
30℃下6个月 | AWAVARDLGEENFK |
合成的全长和截断C末端肽的混合物 | 1013-LVAASQAALGL900-LVAASQAALG |
脱-Len rHA | 673-AWAVAR900-LVAASQAALG951-DLGEENFK1028-?1140-? |
HSA标准品 | 673-AWAVAR900-LVAASQAALG951-DLGEENFK1028-?1140-? |
rHA于30℃下6个月 | 673-AWAVAR900-LVAASQAALG1028-?1140-?951-无信号 |
金属离子 | 波长 | 原子化温度℃ |
Zn | 213.9 | 1800 |
Cu | 327.4 | 2300 |
Fe | 248.8 | 2400 |
Al | 309.8 | 2500 |
Mn | 279.8 | 2200 |
样品 | A<sub>350</sub> | A<sub>403</sub> | A<sub>500</sub> |
1 | 9.95 | 4.10 | 0.8 |
2 | 9.25 | 5.36 | 1.1 |
3 | 7.40 | 3.26 | 0.6 |
4 | 7.20 | 3.60 | 0.6 |
5 | 8.68 | 4.08 | 0.8 |
6 | 11.45 | 6.26 | 1.2 |
7 | 7.20 | 3.70 | 0.8 |
8 | 6.82 | 4.78 | 1.8 |
Claims (8)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US378,859 | 1995-05-25 | ||
US08/378,859 US5728553A (en) | 1992-09-23 | 1995-05-25 | High purity albumin and method of producing |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN03127743A Division CN100584857C (zh) | 1995-05-25 | 1996-02-29 | 高纯度白蛋白生产方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1880334A CN1880334A (zh) | 2006-12-20 |
CN100443499C true CN100443499C (zh) | 2008-12-17 |
Family
ID=23494845
Family Applications (4)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB2004100575838A Expired - Lifetime CN100455597C (zh) | 1995-05-25 | 1996-02-29 | 高纯度白蛋白生产方法 |
CNB2006101006176A Expired - Lifetime CN100443499C (zh) | 1995-05-25 | 1996-02-29 | 高纯度白蛋白生产方法 |
CNB961958243A Expired - Lifetime CN1198844C (zh) | 1995-05-25 | 1996-02-29 | 高纯度白蛋白生产方法 |
CN03127743A Expired - Lifetime CN100584857C (zh) | 1995-05-25 | 1996-02-29 | 高纯度白蛋白生产方法 |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB2004100575838A Expired - Lifetime CN100455597C (zh) | 1995-05-25 | 1996-02-29 | 高纯度白蛋白生产方法 |
Family Applications After (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB961958243A Expired - Lifetime CN1198844C (zh) | 1995-05-25 | 1996-02-29 | 高纯度白蛋白生产方法 |
CN03127743A Expired - Lifetime CN100584857C (zh) | 1995-05-25 | 1996-02-29 | 高纯度白蛋白生产方法 |
Country Status (16)
Country | Link |
---|---|
US (6) | US5728553A (zh) |
EP (2) | EP1031578B1 (zh) |
JP (4) | JP4040088B2 (zh) |
KR (2) | KR100543612B1 (zh) |
CN (4) | CN100455597C (zh) |
AT (2) | ATE265469T1 (zh) |
AU (1) | AU698409B2 (zh) |
CA (1) | CA2220923C (zh) |
DE (2) | DE69611445T2 (zh) |
DK (2) | DK0828759T3 (zh) |
ES (2) | ES2219257T3 (zh) |
GR (1) | GR3035651T3 (zh) |
HK (2) | HK1009456A1 (zh) |
MX (1) | MX9709108A (zh) |
PT (2) | PT828759E (zh) |
WO (1) | WO1996037515A1 (zh) |
Families Citing this family (140)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2686899B1 (fr) * | 1992-01-31 | 1995-09-01 | Rhone Poulenc Rorer Sa | Nouveaux polypeptides biologiquement actifs, leur preparation et compositions pharmaceutiques les contenant. |
US5728553A (en) * | 1992-09-23 | 1998-03-17 | Delta Biotechnology Limited | High purity albumin and method of producing |
DE19538625C2 (de) * | 1995-10-17 | 1999-08-12 | Sartorius Gmbh | Verfahren zur Abtrennung von Albumin aus Serum durch Membranionenaustauschchromatographie |
GB9526733D0 (en) * | 1995-12-30 | 1996-02-28 | Delta Biotechnology Ltd | Fusion proteins |
DE69722391T2 (de) * | 1996-03-13 | 2004-04-22 | Delta Biotechnology Ltd. | Gärungs-steuerungssysteme |
AU2007200859A1 (en) * | 1999-01-30 | 2007-03-22 | Novozymes Delta Limited | Process |
GB9902000D0 (en) | 1999-01-30 | 1999-03-17 | Delta Biotechnology Ltd | Process |
FR2792650B1 (fr) * | 1999-04-20 | 2003-02-28 | Oreal | Equivalent de peau agee, son procede de preparation et son utilisation |
US7780967B2 (en) | 2000-02-08 | 2010-08-24 | Allergan, Inc. | Reduced toxicity Clostridial toxin pharmaceutical compositions |
US20060269575A1 (en) * | 2000-02-08 | 2006-11-30 | Allergan, Inc. | Botulinum toxin pharmaceutical compositions formulated with recombinant albumin |
US20030118598A1 (en) * | 2000-02-08 | 2003-06-26 | Allergan, Inc. | Clostridial toxin pharmaceutical compositions |
CN1331532C (zh) * | 2000-02-08 | 2007-08-15 | 阿勒根公司 | 肉毒杆菌毒素药物组合物 |
US8632785B2 (en) | 2000-02-08 | 2014-01-21 | Allergan, Inc. | Clostridial toxin pharmaceutical composition containing a gelatin fragment |
ES2529300T3 (es) * | 2000-04-12 | 2015-02-18 | Novozymes Biopharma Dk A/S | Proteínas de fusión de albúmina |
US20050100991A1 (en) * | 2001-04-12 | 2005-05-12 | Human Genome Sciences, Inc. | Albumin fusion proteins |
EP1311269B1 (en) | 2000-08-04 | 2012-02-29 | DMI Biosciences, Inc. | Method of using diketopiperazines and composition containing them |
WO2002034785A1 (fr) * | 2000-10-24 | 2002-05-02 | Juridical Foundation The Chemo-Sero-Therapeutic Research Institute | Procede de monomerisation de polymeres d"albumine serique humaine |
JP4798833B2 (ja) | 2000-10-24 | 2011-10-19 | 一般財団法人化学及血清療法研究所 | 加熱処理工程を含むヒト血清アルブミンの製造方法 |
JP4798832B2 (ja) | 2000-10-24 | 2011-10-19 | 一般財団法人化学及血清療法研究所 | ヒト血清アルブミン多量体の除去方法 |
US20050054051A1 (en) * | 2001-04-12 | 2005-03-10 | Human Genome Sciences, Inc. | Albumin fusion proteins |
US7507413B2 (en) * | 2001-04-12 | 2009-03-24 | Human Genome Sciences, Inc. | Albumin fusion proteins |
JP2004536081A (ja) * | 2001-06-13 | 2004-12-02 | トーラス エイチエスエイ エルエルシー | ヒト血清アルブミンの精製 |
ITBO20010426A1 (it) * | 2001-07-06 | 2003-01-06 | Alfa Wassermann Spa | Processo per la purificazione di proteine farmacologicamente attive mediante cromatografia in scambio cationico |
JP2003040798A (ja) * | 2001-07-26 | 2003-02-13 | Nihon Pharmaceutical Co Ltd | 低アルミニウム含有アルブミン製剤およびその製造法 |
US7176278B2 (en) | 2001-08-30 | 2007-02-13 | Biorexis Technology, Inc. | Modified transferrin fusion proteins |
US7482366B2 (en) | 2001-12-21 | 2009-01-27 | X-Ceptor Therapeutics, Inc. | Modulators of LXR |
WO2003059884A1 (en) * | 2001-12-21 | 2003-07-24 | X-Ceptor Therapeutics, Inc. | Modulators of lxr |
EP2261250B1 (en) | 2001-12-21 | 2015-07-01 | Human Genome Sciences, Inc. | GCSF-Albumin fusion proteins |
US20080167238A1 (en) * | 2001-12-21 | 2008-07-10 | Human Genome Sciences, Inc. | Albumin Fusion Proteins |
CA2484556A1 (en) | 2001-12-21 | 2003-07-24 | Human Genome Sciences, Inc. | Albumin fusion proteins |
GB0217033D0 (en) | 2002-07-23 | 2002-08-28 | Delta Biotechnology Ltd | Gene and polypeptide sequences |
NZ539735A (en) * | 2002-10-02 | 2009-07-31 | Dmi Biosciences Inc | Diagnosis and monitoring of diseases using markers, such as diketopiperazines |
EP2517718B1 (en) | 2003-05-15 | 2016-03-02 | Ampio Pharmaceuticals, Inc. | Treatment of T-cell mediated diseases |
US7339347B2 (en) * | 2003-08-11 | 2008-03-04 | Reserve Power Cell, Llc | Apparatus and method for reliably supplying electrical energy to an electrical system |
US8013611B2 (en) * | 2006-07-14 | 2011-09-06 | Reserve Power Cell, Llc | Vehicle battery product and battery monitoring system |
GB0329722D0 (en) * | 2003-12-23 | 2004-01-28 | Delta Biotechnology Ltd | Modified plasmid and use thereof |
WO2006067511A1 (en) | 2004-12-23 | 2006-06-29 | Novozymes Delta Limited | Gene expression technique |
GB0329681D0 (en) | 2003-12-23 | 2004-01-28 | Delta Biotechnology Ltd | Gene expression technique |
BRPI0418304A (pt) * | 2004-01-07 | 2007-05-02 | Trimeris Inc | peptìdeo sintético, uso do mesmo, composição farmacêutica, seqüência de nucleotìdeos, e, métodos para inibição da transmissão de hiv para uma célula, para inibição da fusão de hiv, e para tratamento de um indivìduo infectado com hiv |
ATE428722T1 (de) | 2004-01-20 | 2009-05-15 | Chemo Sero Therapeut Res Inst | Verfahren zur herstellung von humanserumalbumin durch wärmebehandlung in gegenwart von zweiwertigem kation |
WO2005110374A1 (en) * | 2004-04-30 | 2005-11-24 | Allergan, Inc. | Intraocular drug delivery systems containing a therapeutic component, a cyclodextrin, and a polymeric component |
US20070059336A1 (en) * | 2004-04-30 | 2007-03-15 | Allergan, Inc. | Anti-angiogenic sustained release intraocular implants and related methods |
US8591885B2 (en) * | 2004-04-30 | 2013-11-26 | Allergan, Inc. | Carbonic anhydrase inhibitor sustained release intraocular drug delivery systems |
US20060182783A1 (en) * | 2004-04-30 | 2006-08-17 | Allergan, Inc. | Sustained release intraocular drug delivery systems |
WO2006094185A2 (en) * | 2005-03-03 | 2006-09-08 | Dmi Biosciences Inc. | Quantification of proteins |
US7598700B2 (en) * | 2005-03-30 | 2009-10-06 | Reserve Power Cell, Llc | Tamper resistant battery and battery warranty and performance tracking system |
MY144344A (en) * | 2005-04-08 | 2011-09-15 | Ciba Holding Inc | Adsorbents comprising anthraquinone dye-ligands for the separation of biological materials |
DE102005023155A1 (de) | 2005-05-13 | 2006-11-16 | Albutec Gmbh | Albuminlösung |
US8323666B2 (en) | 2005-08-01 | 2012-12-04 | Allergan, Inc. | Botulinum toxin compositions |
GB0518460D0 (en) * | 2005-09-09 | 2005-10-19 | Univ Nottingham Trent | Protein assay |
JP4682251B2 (ja) | 2006-02-02 | 2011-05-11 | トリメリス,インコーポレーテッド | 改善された生物学的特性を有するhiv融合阻害剤ペプチド |
JP2007284425A (ja) * | 2006-03-20 | 2007-11-01 | Nokodai Tlo Kk | タンパク質の精製方法 |
CA2654055A1 (en) | 2006-06-07 | 2007-12-21 | Human Genome Sciences, Inc. | Albumin fusion proteins |
AU2007274035A1 (en) * | 2006-07-13 | 2008-01-17 | Novozymes Biopharma Dk A/S | Process for preparing particles of proteinaceous material |
KR101193722B1 (ko) | 2006-07-24 | 2013-01-11 | 바이오렉시스 파마슈티칼 코포레이션 | 엑센딘 융합 단백질 |
US10829733B2 (en) * | 2007-01-04 | 2020-11-10 | Biolamina Ab | Composition and method for enabling proliferation of pluripotent human stem cells |
WO2008124013A1 (en) * | 2007-04-03 | 2008-10-16 | Trimeris, Inc. | Novel formulations for delivery of antiviral peptide therapeutics |
CN101104635B (zh) * | 2007-04-30 | 2010-11-03 | 北京济普霖生物技术有限公司 | 一种从转基因牛乳中纯化重组人α-乳清白蛋白的方法 |
US20110124576A1 (en) * | 2007-08-08 | 2011-05-26 | Novozymes A/S | Transferrin Variants and Conjugates |
CN101874038A (zh) * | 2007-09-25 | 2010-10-27 | 特里梅里斯公司 | 治疗性抗-hiv肽的合成方法 |
EP2261661A4 (en) * | 2008-03-31 | 2011-04-20 | Sekisui Medical Co Ltd | CLEANED SERUM ALBUMIN AND IMMUNOLOGY MEASUREMENT PROCESS |
JP2009298783A (ja) * | 2008-05-15 | 2009-12-24 | R Tec Ueno:Kk | ドライアイおよび/または角結膜障害処置のための医薬組成物 |
WO2009146320A1 (en) | 2008-05-27 | 2009-12-03 | Dmi Life Sciences, Inc. | Therapeutic methods and compounds |
AU2009264214B2 (en) | 2008-06-24 | 2013-06-06 | Technische Universitaet Muenchen | Muteins of hNGAL and related proteins with affinity for a given target |
ES2630253T3 (es) | 2009-02-11 | 2017-08-18 | Albumedix A/S | Variantes de albúmina y conjugados |
CN102369276B (zh) | 2009-02-20 | 2015-02-04 | 文特里亚生物科学公司 | 含有蛋白质组合的细胞培养基 |
DE102009013914B4 (de) * | 2009-03-19 | 2011-05-05 | Bruker Daltonik Gmbh | Kalibriersubstanzen für Atmosphärendruck-Ionenquellen |
DK2427486T3 (en) * | 2009-05-07 | 2015-05-26 | Novozymes Biopharma Dk As | A process for purifying albumin |
BR112012002709A2 (pt) | 2009-08-05 | 2019-04-30 | Pieris Ag | formulações de liberação controlada de muteínas de lipocalina |
DK2467399T3 (en) * | 2009-08-20 | 2017-01-23 | Baxalta Inc | Purification of vWF for increased removal of non-lipid-enveloped viruses |
CN102741280B (zh) | 2009-10-30 | 2015-12-02 | 诺维信生物制药丹麦公司 | 白蛋白变体 |
JP5913120B2 (ja) | 2009-12-07 | 2016-05-11 | ピエリス アーゲーPieris Ag | 所定の標的に対して親和性を有するヒトリポカリン2(Lcn2、hNGAL)の突然変異タンパク質 |
AU2011207425A1 (en) * | 2010-01-25 | 2012-08-16 | Ventria Bioscience | Methods and compositions for improving protein production |
US10233228B2 (en) | 2010-04-09 | 2019-03-19 | Albumedix Ltd | Albumin derivatives and variants |
NZ603562A (en) | 2010-06-08 | 2014-07-25 | Pieris Ag | Tear lipocalin muteins binding il-4 r alpha |
SG10201505785QA (en) | 2010-08-16 | 2015-09-29 | Pieris Ag | Binding proteins for hepcidin |
US8507496B2 (en) | 2010-09-07 | 2013-08-13 | Dmi Acquisition Corp. | Treatment of diseases |
US9260492B2 (en) | 2010-11-15 | 2016-02-16 | Pieris Ag | Muteins of human lipocalin 2 with affinity for glypican-3 (GPC-3) |
EP2646552B1 (en) | 2010-12-02 | 2017-07-05 | Pieris Pharmaceuticals GmbH | Muteins of human lipocalin 2 with affinity for ctla-4 |
PL221899B1 (pl) | 2011-05-06 | 2016-06-30 | Wrocławskie Centrum Badań Eit + Spółka Z Ograniczoną | Czysta albumina oraz sposób jej otrzymywania i detekcji |
CN103649111B (zh) | 2011-07-05 | 2018-03-13 | 阿尔布梅迪克斯医疗公司 | 白蛋白制剂和用途 |
MX2014003856A (es) | 2011-10-10 | 2015-01-16 | Ampio Pharmaceuticals Inc | Dispositivos medicos implantables con tolerancia inmune incrementada y metodos para hacerlos e implantarlos. |
JP6203734B2 (ja) | 2011-10-10 | 2017-09-27 | アンピオ ファーマシューティカルズ,インコーポレイテッド | 変形性関節疾患の治療 |
US10881710B2 (en) | 2011-10-28 | 2021-01-05 | Ampio Pharmaceuticals, Inc. | Treatment of rhinitis |
US20140315817A1 (en) | 2011-11-18 | 2014-10-23 | Eleven Biotherapeutics, Inc. | Variant serum albumin with improved half-life and other properties |
WO2013087660A1 (en) | 2011-12-13 | 2013-06-20 | Pieris Ag | Methods for preventing or treating certain disorders by inhibiting binding of il-4 and/or il-13 to their respective receptors |
EP2825556B1 (en) | 2012-03-16 | 2018-01-03 | Albumedix A/S | Albumin variants |
US9522940B2 (en) | 2012-05-23 | 2016-12-20 | Pieris Pharmaceuticals Gmbh | Lipocalin muteins with binding-affinity for glypican-3 (GPC-3) and use of lipocalin muteins for target-specific delivery to cells expressing GPC-3 |
US20140031527A1 (en) * | 2012-07-27 | 2014-01-30 | Csl Limited | Method for polishing albumin |
WO2014072481A1 (en) | 2012-11-08 | 2014-05-15 | Novozymes Biopharma Dk A/S | Albumin variants |
US10526384B2 (en) | 2012-11-19 | 2020-01-07 | Pieris Pharmaceuticals Gmbh | Interleukin-17A-specific and interleukin-23-specific binding polypeptides and uses thereof |
US20140186447A1 (en) * | 2012-12-28 | 2014-07-03 | Abraxis Bioscience, Llc | Nanoparticle compositions of albumin and paclitaxel |
JP6128677B2 (ja) * | 2013-02-05 | 2017-05-17 | 公立大学法人大阪市立大学 | 神経細胞の遊走障害を伴う疾患の判定方法及びその利用 |
BR112015021681A2 (pt) | 2013-03-14 | 2017-11-14 | Daiichi Sankyo Co Ltd | proteínas de ligação para pcsk9 |
KR20150132508A (ko) | 2013-03-15 | 2015-11-25 | 앰피오 파마슈티컬스 인코퍼레이티드 | 줄기세포의 가동화, 회귀, 증식 및 분화를 위한 조성물 및 이의 사용 방법 |
CN103694343B (zh) * | 2013-12-26 | 2016-05-25 | 扬州艾迪生物科技有限公司 | 一种从尿液中制备人血白蛋白的方法 |
EP3094650A2 (en) | 2014-01-13 | 2016-11-23 | Pieris Pharmaceuticals GmbH | Multi-specific polypeptide useful for localized tumor immunomodulation |
EP4147761A1 (en) * | 2014-04-30 | 2023-03-15 | Novo Nordisk A/S | Methods for the purification of proteins using caprylic acid |
MX2016015235A (es) | 2014-05-22 | 2017-06-29 | Pieris Pharmaceuticals Gmbh | Nuevos polipeptidos de union especifica y usos de los mismos. |
EP4066836A1 (en) | 2014-08-18 | 2022-10-05 | Ampio Pharmaceuticals, Inc. | Treatment of joint conditions |
CN104628830A (zh) * | 2015-01-23 | 2015-05-20 | 深圳康泰生物制品股份有限公司 | 重组酿酒酵母表达HBsAg的制备工艺及其分离纯化工艺、HBsAg和乙肝疫苗 |
CA2973640A1 (en) | 2015-01-28 | 2016-08-04 | Rachida Siham Bel Aiba | Novel proteins specific for angiogenesis |
EA035824B1 (ru) | 2015-02-18 | 2020-08-17 | Пайерис Фармасьютикалс Гмбх | Новые белки, специфичные к пиовердину и пиохелину |
US10705070B1 (en) | 2015-03-05 | 2020-07-07 | Abraxis Bioscience, Llc | Methods of assessing suitability of use of pharmaceutical compositions of albumin and poorly water soluble drug |
US10527604B1 (en) | 2015-03-05 | 2020-01-07 | Abraxis Bioscience, Llc | Methods of assessing suitability of use of pharmaceutical compositions of albumin and paclitaxel |
DK3292137T3 (da) | 2015-05-04 | 2022-10-17 | Pieris Pharmaceuticals Gmbh | Proteiner specifikke for cd137 |
US10865250B2 (en) | 2015-05-04 | 2020-12-15 | Pieris Pharmaceuticals Gmbh | Anti-cancer fusion polypeptide |
WO2016184882A1 (en) | 2015-05-18 | 2016-11-24 | Pieris Pharmaceuticals Gmbh | Anti-cancer fusion polypeptide |
SG11201707872WA (en) | 2015-05-18 | 2017-10-30 | Pieris Pharmaceuticals Gmbh | Muteins of human lipocalin 2 with affinity for glypican-3 (gpc3) |
US11389512B2 (en) | 2015-06-22 | 2022-07-19 | Ampio Pharmaceuticals, Inc. | Use of low molecular weight fractions of human serum albumin in treating diseases |
EP3115371A1 (en) | 2015-07-07 | 2017-01-11 | Sanofi | Fusion molecules |
CA2988831A1 (en) | 2015-07-15 | 2017-01-19 | Pieris Pharmaceuticals Gmbh | Novel proteins specific for lag-3 |
JP7007261B2 (ja) | 2015-08-20 | 2022-01-24 | アルブミディクス リミティド | アルブミン変異体及びコンジュゲート |
FR3040882A1 (fr) * | 2015-09-10 | 2017-03-17 | Lab Francais Du Fractionnement | Composition liquide d'albumine humaine a usage therapeutique |
BR112018010887A2 (pt) | 2015-11-30 | 2018-11-21 | Pieris Australia Pty Ltd | polipeptídeo de fusão |
TW201725212A (zh) | 2015-12-10 | 2017-07-16 | 第一三共股份有限公司 | 特異性於降鈣素基因相關胜肽的新穎蛋白 |
BR112018012851A2 (pt) | 2015-12-22 | 2018-12-26 | Albumedix Ltd | cepas de expressão de proteína melhoradas |
KR102050852B1 (ko) * | 2016-03-11 | 2019-12-03 | 주식회사 스템온 | 세포 리프로그래밍 장치 |
CN110198952B (zh) * | 2016-08-17 | 2024-03-01 | 勃林格殷格翰国际公司 | 制备含有生物分子的高度浓缩的液体制剂的方法 |
WO2018065491A1 (en) | 2016-10-04 | 2018-04-12 | Albumedix A/S | Uses of recombinant yeast-derived serum albumin |
WO2018087108A1 (en) | 2016-11-09 | 2018-05-17 | Pieris Pharmaceuticals Gmbh | Proteins specific for cd137 |
WO2018134274A1 (en) | 2017-01-18 | 2018-07-26 | Pieris Pharmaceuticals Gmbh | Lipocalin muteins with binding affinity for lag-3 |
CN110678481B (zh) * | 2017-03-16 | 2023-10-31 | 伊沃芙生物制品公司 | 用于纯化白蛋白的方法 |
CN111032871A (zh) | 2017-06-20 | 2020-04-17 | 阿尔布梅迪克斯医疗有限公司 | 改良的表达蛋白质的菌株 |
CN110563833A (zh) * | 2018-06-06 | 2019-12-13 | 中国计量科学研究院 | 一种人血白蛋白标准物质原料的制备方法及其产品和应用 |
CN112789292A (zh) | 2018-07-31 | 2021-05-11 | 皮里斯制药有限公司 | 对cd137和pd-l1特异性的新型融合蛋白 |
CN109734796B (zh) * | 2019-02-01 | 2022-04-15 | 广州蕊特生物科技有限公司 | 一种从溶血血清中分离白蛋白的工艺 |
CN109776673B (zh) * | 2019-02-20 | 2022-03-29 | 天津理工大学 | 一种适合中试量产的高纯度牛血清白蛋白纯化工艺 |
WO2020173897A1 (en) | 2019-02-26 | 2020-09-03 | Pieris Pharmaceuticals Gmbh | Novel fusion proteins specific for cd137 and gpc3 |
CN110229229A (zh) * | 2019-07-10 | 2019-09-13 | 甘肃养泰和生物科技有限公司 | 一种从牛血浆中提取纯化细胞培养级牛血清白蛋白的生产方法及其应用 |
WO2021086946A1 (en) | 2019-10-28 | 2021-05-06 | Abraxis Bioscience, Llc | Pharmaceutical compositions of albumin and rapamycin |
US20230227568A1 (en) | 2020-06-05 | 2023-07-20 | Pieris Pharmaceuticals Gmbh | Multimeric immunomodulator targeting 4-1bb |
US11739166B2 (en) | 2020-07-02 | 2023-08-29 | Davol Inc. | Reactive polysaccharide-based hemostatic agent |
JP2024501601A (ja) | 2020-12-08 | 2024-01-15 | 通化安睿特生物製薬股▲フェン▼有限公司 | 組換えタンパク質を精製する方法 |
CN112592399A (zh) * | 2020-12-15 | 2021-04-02 | 五河县康爱生物科技有限公司 | 一种从牛血清中分离牛血清白蛋白的制备方法及装置 |
EP4320141A1 (en) | 2021-04-08 | 2024-02-14 | Pieris Pharmaceuticals GmbH | Novel lipocalin muteins specific for connective tissue growth factor (ctgf) |
WO2022243341A1 (en) | 2021-05-18 | 2022-11-24 | Pieris Pharmaceuticals Gmbh | Lipocalin muteins with binding affinity for ox40 |
CN113735963A (zh) * | 2021-09-10 | 2021-12-03 | 山东健通生物科技有限公司 | 一种重组人血清白蛋白纯化过程去除色素的方法 |
CN114316088B (zh) * | 2021-12-22 | 2022-09-09 | 中国水产科学研究院黄海水产研究所 | 亲和树脂、制备方法及其在分离纯化藻蓝蛋白中的应用 |
CN116120392B (zh) * | 2023-04-18 | 2023-08-01 | 上海健士拜生物科技有限公司 | 聚体蛋白的纯化方法 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1992009303A1 (en) * | 1990-11-30 | 1992-06-11 | The Green Cross Corporation | Albumin preparation and preservation thereof |
CN1087914A (zh) * | 1992-12-11 | 1994-06-15 | 上海莱士血制品有限公司 | 白蛋白的纯化方法 |
Family Cites Families (54)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9019919D0 (en) * | 1990-09-12 | 1990-10-24 | Delta Biotechnology Ltd | Purification of proteins |
US2433905A (en) | 1943-11-01 | 1948-01-06 | Jr Walter L Hughes | Method for the crystallization of albumin and the preparation of protein products therefrom |
AT317418B (de) * | 1972-06-16 | 1974-08-25 | Brigitte Panhofer | Verfahren zur Herstellung von intravenös beim Menschen anwendbarem Humanalbumin aus menschlichen Placenten |
FR2190437B1 (zh) | 1972-07-05 | 1975-08-08 | Merieux Inst | |
CA1044537A (en) | 1973-05-09 | 1978-12-19 | Amf Incorporated | Filter medium and process |
DE2537123A1 (de) * | 1975-08-20 | 1977-03-03 | New Zealand Inventions Dev | Verfahren zur herstellung von albumin |
SE405549B (sv) * | 1975-10-09 | 1978-12-18 | Pharmacia Fine Chemicals Ab | Forfarande for isolering av albumin ur plasmaprodukter genom kromatografisk fraktionering |
US4043997A (en) * | 1976-05-28 | 1977-08-23 | Cutter Laboratories, Inc. | Method for isolating albumin using insoluble supports coupled to a dye |
US4075197A (en) * | 1976-09-20 | 1978-02-21 | Monsanto Company | Serum albumin production |
IN150740B (zh) | 1978-11-24 | 1982-12-04 | Hoffmann La Roche | |
US4228154A (en) * | 1979-02-26 | 1980-10-14 | Armour Pharmaceutical Company | Purification of plasma albumin by ion exchange chromatography |
US4222934A (en) * | 1979-04-12 | 1980-09-16 | American National Red Cross | Preparation of albumin using ethanol |
GB2053926B (en) | 1979-07-20 | 1983-02-23 | Atkinson A | Albumin extraction by affinity chromatography |
US4350156A (en) * | 1980-05-29 | 1982-09-21 | Japan Foundation For Artificial Organs | Method and apparatus for on-line filtration removal of macromolecules from a physiological fluid |
IL66614A (en) * | 1981-08-28 | 1985-09-29 | Genentech Inc | Method of constructing a dna sequence encoding a polypeptide,microbial production of human serum albumin,and pharmaceutical compositions comprising it |
US4391801A (en) | 1981-10-29 | 1983-07-05 | Cutter Laboratories, Inc. | Plasma protein fraction substantially free of acetate ions |
FR2543448A1 (fr) * | 1983-04-01 | 1984-10-05 | Rhone Poulenc Spec Chim | Procede de fractionnement du plasma |
US4748120A (en) * | 1983-05-02 | 1988-05-31 | Diamond Scientific Co. | Photochemical decontamination treatment of whole blood or blood components |
DE3344656A1 (de) * | 1983-12-09 | 1985-06-13 | Lentia GmbH Chem. u. pharm. Erzeugnisse - Industriebedarf, 8000 München | Verfahren zur herstellung einer serumproteinloesung |
CA1286622C (en) * | 1986-04-28 | 1991-07-23 | Chokyun Rha | Method for clarifying and stabilizing cell culture media |
JPS62294621A (ja) | 1986-06-13 | 1987-12-22 | Green Cross Corp:The | アルブミンの回収方法 |
JPS6383100A (ja) * | 1986-09-26 | 1988-04-13 | Green Cross Corp:The | ヒト尿中アルブミンの製造方法 |
US4833233A (en) * | 1987-08-20 | 1989-05-23 | The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration | Human serum albumin crystals and method of preparation |
IL88326A (en) | 1987-11-18 | 1993-03-15 | Gist Brocades Nv | Purification of serum albumin |
US4990447A (en) * | 1988-06-24 | 1991-02-05 | Gist-Brocades Nv | Process for the purification of serum albumin |
FR2649991B2 (fr) | 1988-08-05 | 1994-03-04 | Rhone Poulenc Sante | Utilisation de derives stables du plasmide pkd1 pour l'expression et la secretion de proteines heterologues dans les levures du genre kluyveromyces |
JP3554796B2 (ja) * | 1988-10-31 | 2004-08-18 | 三菱ウェルファーマ株式会社 | アルブミン製剤及びその製造方法 |
US4891221A (en) * | 1988-11-23 | 1990-01-02 | Edward Shanborm | Whole blood antiviral process and composition |
FR2648048B1 (fr) * | 1989-06-08 | 1994-06-03 | Lille Transfusion Sanguine | Procede de preparation de solutions d'albumine purifiee |
GB8913586D0 (en) | 1989-06-13 | 1989-08-02 | Technicol Limited | A method of determining the glycosylated protein level of a sample and an apparatus for use in the method |
JPH0768137B2 (ja) * | 1989-06-15 | 1995-07-26 | 株式会社ミドリ十字 | アルブミン製剤及びその製法 |
SE500110C2 (sv) | 1989-06-27 | 1994-04-18 | Kabi Pharmacia Ab | Sätt att rena ett protein från därtill bundna flervärda metalljoner |
JPH0671434B2 (ja) | 1989-09-18 | 1994-09-14 | 株式会社ミドリ十字 | ヒト血清アルブミンの製造方法 |
CA2022165C (en) | 1989-10-05 | 1999-11-23 | Chong E. Chang | Albumin purification |
US5250662A (en) * | 1989-10-05 | 1993-10-05 | Alpha Therapeutic Corporation | Albumin purification |
ES2224094T3 (es) * | 1990-04-19 | 2005-03-01 | Bayer Corporation | Procedimiento para preparar seroalbumina normal (humana) esencialmente monomerica. |
JP3230091B2 (ja) * | 1990-06-25 | 2001-11-19 | ウェルファイド株式会社 | ヒト血清アルブミンの着色抑制方法 |
JP2982296B2 (ja) | 1990-11-19 | 1999-11-22 | 吉富製薬株式会社 | アルブミン含有水溶液の精製法 |
FR2672604B1 (fr) | 1991-02-07 | 1995-05-05 | Pasteur Merieux Serums Vacc | Procede pour isoler de l'albumine humaine a partir du surnageant iv, notamment iv-4, ou de la fraction v de cohn ou d'un surnageant ou fraction analogue. |
US5284777A (en) * | 1991-03-04 | 1994-02-08 | Isolab, Inc. | Combined glycated hemoglobin and immunoturbidometric glycated albumin assay from whole blood lysate |
US5330901A (en) * | 1991-04-26 | 1994-07-19 | Research Corporation Technologies, Inc. | Expression of human serum albumin in Pichia pastoris |
IE922257A1 (en) * | 1991-07-12 | 1993-01-13 | Gist Brocades Nv | Process for the purification of serum albumin |
FR2686620B1 (fr) * | 1992-01-27 | 1995-06-23 | Rhone Poulenc Rorer Sa | Serum-albumine humaine, preparation et utilisation. |
US5281582A (en) * | 1992-02-27 | 1994-01-25 | Alliance Pharmaceuticals, Corp. | Serum growth factor |
US5440018A (en) * | 1992-05-20 | 1995-08-08 | The Green Cross Corporation | Recombinant human serum albumin, process for producing the same and pharmaceutical preparation containing the same |
JP3360315B2 (ja) * | 1992-07-31 | 2002-12-24 | 三菱ウェルファーマ株式会社 | ヒト血清アルブミンの高度精製方法 |
DE4226971C2 (de) | 1992-08-14 | 1997-01-16 | Widmar Prof Dr Tanner | Modifizierte Pilzzellen und Verfahren zur Herstellung rekombinanter Produkte |
US5728553A (en) * | 1992-09-23 | 1998-03-17 | Delta Biotechnology Limited | High purity albumin and method of producing |
CA2116385A1 (en) * | 1993-02-25 | 1994-08-26 | Akinori Sumi | Human serum albumin and process for producing the same |
SE9301583D0 (sv) | 1993-05-07 | 1993-05-07 | Kabi Pharmacia Ab | Yeast strain and methods for expressing heterologous proteins in yeast |
JP3702474B2 (ja) | 1994-06-01 | 2005-10-05 | 三菱ウェルファーマ株式会社 | 血清アルブミン製剤の製造方法 |
DK0699687T3 (da) * | 1994-08-31 | 2004-04-26 | Mitsubishi Pharma Corp | Fremgangsmåde til oprensning af rekombinant humant serumalbumin |
JPH09209303A (ja) | 1996-02-05 | 1997-08-12 | Hokkaido Supuritsuton Kogyo Kk | 舗装ブロック |
WO1997031947A1 (en) | 1996-02-29 | 1997-09-04 | Delta Biotechnology Limited | High purity albumin production process |
-
1995
- 1995-05-25 US US08/378,859 patent/US5728553A/en not_active Expired - Lifetime
-
1996
- 1996-02-29 JP JP53545796A patent/JP4040088B2/ja not_active Expired - Lifetime
- 1996-02-29 US US08/952,558 patent/US6638740B1/en not_active Expired - Fee Related
- 1996-02-29 KR KR1020047011825A patent/KR100543612B1/ko not_active IP Right Cessation
- 1996-02-29 DK DK96904190T patent/DK0828759T3/da active
- 1996-02-29 AT AT00201960T patent/ATE265469T1/de active
- 1996-02-29 EP EP00201960A patent/EP1031578B1/en not_active Expired - Lifetime
- 1996-02-29 ES ES00201960T patent/ES2219257T3/es not_active Expired - Lifetime
- 1996-02-29 CN CNB2004100575838A patent/CN100455597C/zh not_active Expired - Lifetime
- 1996-02-29 CN CNB2006101006176A patent/CN100443499C/zh not_active Expired - Lifetime
- 1996-02-29 DE DE69611445T patent/DE69611445T2/de not_active Expired - Lifetime
- 1996-02-29 DE DE69632353T patent/DE69632353T2/de not_active Expired - Lifetime
- 1996-02-29 KR KR1019970708469A patent/KR100566606B1/ko not_active IP Right Cessation
- 1996-02-29 AU AU48380/96A patent/AU698409B2/en not_active Ceased
- 1996-02-29 WO PCT/GB1996/000449 patent/WO1996037515A1/en not_active Application Discontinuation
- 1996-02-29 PT PT96904190T patent/PT828759E/pt unknown
- 1996-02-29 PT PT00201960T patent/PT1031578E/pt unknown
- 1996-02-29 CA CA002220923A patent/CA2220923C/en not_active Expired - Lifetime
- 1996-02-29 EP EP96904190A patent/EP0828759B1/en not_active Expired - Lifetime
- 1996-02-29 ES ES96904190T patent/ES2156991T3/es not_active Expired - Lifetime
- 1996-02-29 CN CNB961958243A patent/CN1198844C/zh not_active Expired - Lifetime
- 1996-02-29 AT AT96904190T patent/ATE198482T1/de active
- 1996-02-29 DK DK00201960T patent/DK1031578T3/da active
- 1996-02-29 CN CN03127743A patent/CN100584857C/zh not_active Expired - Lifetime
-
1997
- 1997-11-14 US US08/970,648 patent/US6034221A/en not_active Expired - Lifetime
- 1997-11-25 MX MX9709108A patent/MX9709108A/es unknown
-
1998
- 1998-08-26 HK HK98110246A patent/HK1009456A1/xx not_active IP Right Cessation
-
2001
- 2001-03-29 GR GR20010400501T patent/GR3035651T3/el unknown
-
2002
- 2002-05-31 JP JP2002160250A patent/JP4037174B2/ja not_active Expired - Lifetime
- 2002-11-21 US US10/301,357 patent/US20030187226A1/en not_active Abandoned
-
2004
- 2004-06-22 US US10/873,504 patent/US7223561B2/en not_active Expired - Fee Related
-
2005
- 2005-06-15 HK HK05105030.6A patent/HK1072436A1/xx not_active IP Right Cessation
-
2006
- 2006-07-04 JP JP2006184756A patent/JP4372772B2/ja not_active Expired - Lifetime
-
2007
- 2007-04-23 US US11/738,582 patent/US7601515B2/en not_active Expired - Fee Related
- 2007-07-30 JP JP2007197742A patent/JP4372813B2/ja not_active Expired - Lifetime
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1992009303A1 (en) * | 1990-11-30 | 1992-06-11 | The Green Cross Corporation | Albumin preparation and preservation thereof |
CN1087914A (zh) * | 1992-12-11 | 1994-06-15 | 上海莱士血制品有限公司 | 白蛋白的纯化方法 |
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN100443499C (zh) | 高纯度白蛋白生产方法 | |
KR0153516B1 (ko) | 폴리펩티드 | |
JPH11509525A (ja) | 高純度アルブミンの製造方法 | |
Kobayashi et al. | The development of recombinant human serum albumin | |
US20120165509A1 (en) | method for isolating and purifying recombinant human serum albumin from transgenic rice grain | |
JPH0646873A (ja) | ヒト血清アルブミンの高度精製方法 | |
WO1997031947A1 (en) | High purity albumin production process | |
US6103502A (en) | Ultrafiltration process for desalination and concentration of a peptide in a cell-free fermentation medium | |
JP2869417B2 (ja) | 遺伝子操作により得られるヒト血清アルブミン | |
JPH11191A (ja) | 遺伝子操作により得られるヒト血清アルブミン | |
Bohner | Expression, purification, crystallization and structure determination of herpes simplex virus type 1 thymidine kinase | |
JPH0538287A (ja) | ウサギプレプロ血清アルブミン遺伝子、該遺伝子を含む組換えプラスミドdna、該組換えプラスミドdnaで形質転換された微生物及び該微生物を用いたウサギ血清アルブミンの製造方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C56 | Change in the name or address of the patentee |
Owner name: NOVOZYMES UK BIO-PHARMACEUTICAL CO., LTD. Free format text: FORMER NAME: NOWISON DARTA CO., LTD. Owner name: NOWISON DARTA CO., LTD. Free format text: FORMER NAME: DELTA BIOTECHNOLOGY CO., LTD. |
|
CP03 | Change of name, title or address |
Address after: British Nottinghamshire Patentee after: NOVOZYMES BIOPHARMA DK A/S Address before: British Nottinghamshire Patentee before: NOVOZYMES DELTA LTD. Address after: British Nottinghamshire Patentee after: NOVOZYMES DELTA LTD. Address before: British Nottinghamshire Patentee before: Delta Biotechnology Ltd. |
|
ASS | Succession or assignment of patent right |
Owner name: NOVOZYMES BIOPOLYMER AS Free format text: FORMER OWNER: NOVOZYMES BIOPHARMA UK CO., LTD. Effective date: 20100919 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: NOTTINGHAMSHIRE, UK TO: BAGSVAERD, DENMARK |
|
TR01 | Transfer of patent right |
Effective date of registration: 20100919 Address after: Denmark bagsvaerd Patentee after: NOVOZYMES BIOPHARMA DK A/S Address before: British Nottinghamshire Patentee before: NOVOZYMES BIOPHARMA DK A/S |
|
CX01 | Expiry of patent term |
Granted publication date: 20081217 |
|
EXPY | Termination of patent right or utility model |